Literature DB >> 3423748

Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year.

A Larsen1, J Thoen.   

Abstract

Hand radiography of 200 patients with rheumatoid arthritis RA was repeated after an interval of 12 months. Twenty joints including ten metacarpophalangeal joints, eight proximal interphalangeal joints and two interphalangeal joints of the thumbs were assessed. The number of joints with erosion was recorded, being referred to as Erosion Score. Additionally, each joint was graded on a zero to five point scale and the gradings of the individual joints were summed to form a score referred to as Damage Score. The progression in these scores during 12 months was recorded. The radiological joint damage was found to develop rapidly during the first years after disease onset and to assume a slow rate of increase after 9 years of the disease. The results imply that the disease duration is a critical feature for therapeutic studies. We suggest that patients with disease duration of less than 36 months only are suitable for therapeutic trials of RA and that the follow-up time should be at least 18 months if radiological assessment is used.

Entities:  

Mesh:

Year:  1987        PMID: 3423748     DOI: 10.3109/03009748709165409

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  26 in total

1.  Articular damage in late rheumatoid arthritis.

Authors:  Emel Eksioglu; Reyhan Tuncay; Eda Gurcay; Ajda Bal; Aytul Cakci
Journal:  Clin Rheumatol       Date:  2006-04-22       Impact factor: 2.980

2.  Potential clinical relevance of digital radiogrammetry for quantification of periarticular bone demineralization in patients suffering from rheumatoid arthritis depending on severity and compared with DXA.

Authors:  J Böttcher; A Malich; A Pfeil; A Petrovitch; G Lehmann; J P Heyne; G Hein; W A Kaiser
Journal:  Eur Radiol       Date:  2003-11-05       Impact factor: 5.315

Review 3.  Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis.

Authors:  Gabriel Baron; Isabelle Boutron; Bruno Giraudeau; Philippe Ravaud
Journal:  Ann Rheum Dis       Date:  2006-12-11       Impact factor: 19.103

Review 4.  [Quantitative imaging in rheumatoid arthritis: from scoring to measurement].

Authors:  P Peloschek; G Langs; A Valentinitsch; M Bubale; T Schlager; C Müller-Mang; F Kainberger
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

5.  Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis.

Authors:  Jonathan J Miner; Lindsey E Cook; Jun P Hong; Amber M Smith; Justin M Richner; Raeann M Shimak; Alissa R Young; Kristen Monte; Subhajit Poddar; James E Crowe; Deborah J Lenschow; Michael S Diamond
Journal:  Sci Transl Med       Date:  2017-02-01       Impact factor: 17.956

Review 6.  [Measurement instead of scoring in rheumatology: new quantitative imaging and processing methods in radiology].

Authors:  P Peloschek; C Müller-Mang; K Friedrich; G Langs; R Donner; A Valentinitsch; F Kainberger
Journal:  Z Rheumatol       Date:  2008-02       Impact factor: 1.372

7.  Disease remission in rheumatoid arthritis.

Authors:  A R Cabral
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

8.  Does the serum level of IgA-alpha-1-antitrypsin complex correlate with radiological progression in early rheumatoid arthritis? A 3-year follow-up study.

Authors:  J K Lacki; T Schochat; W Porawaska; S H Mackiewicz; W Müller
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Disease activity and the course of elbow joint deterioration over 10 years in the patients with early rheumatoid arthritis.

Authors:  Asami Abe; Hajime Ishikawa; Akira Murasawa; Kiyoshi Nakazono
Journal:  Clin Rheumatol       Date:  2007-12-20       Impact factor: 2.980

10.  Functions of polymorphonuclear leukocytes in early rheumatoid arthritis.

Authors:  M Leirisalo-Repo; L Paimela; S Koskimies; H Repo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.